Stock Research: AngioDynamics

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

AngioDynamics

NasdaqGS:ANGO US03475V1017
19
  • Value
    38
  • Growth
    23
  • Safety
    Safety
    57
  • Combined
    11
  • Sentiment
    42
  • 360° View
    360° View
    19
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

AngioDynamics is a medical technology company focused on restoring healthy blood flow and expanding cancer treatment options. The company operates in the Med Tech and Med Device industries. Its devices are used by professional healthcare providers. In the last fiscal year, the company had a market cap of $366 million, profits of $158 million, and revenue of $292 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 19 (better than 19% compared with alternatives), overall professional sentiment and financial characteristics for the stock AngioDynamics are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for AngioDynamics. Only the consolidated Value Rank has an attractive rank of 57, which means that the share price of AngioDynamics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 57% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 23, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 38, meaning the company has a riskier financing structure than 62% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 58% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 42. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 61 85 51
Growth
23 35 9 15
Safety
Safety
38 96 91 31
Sentiment
42 61 28 1
360° View
360° View
19 67 61 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
89 93 29 52
Opinions Change
21 50 50 13
Pro Holdings
n/a 32 23 26
Market Pulse
59 57 73 13
Sentiment
42 61 28 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 61 85 51
Growth
23 35 9 15
Safety Safety
38 96 91 31
Combined
11 80 87 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
31 31 31 4
Price vs. Earnings (P/E)
62 65 95 75
Price vs. Book (P/B)
59 70 97 92
Dividend Yield
1 1 1 1
Value
57 61 85 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
31 39 31 23
Profit Growth
4 29 4 6
Capital Growth
7 1 83 31
Stock Returns
93 99 15 85
Growth
23 35 9 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
84 100 66 72
Refinancing
49 62 83 31
Liquidity
4 46 45 23
Safety Safety
38 96 91 31

Similar Stocks

Discover high‑ranked alternatives to AngioDynamics and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.